BridgeMD
New treatment option for Rare Diseases
Official title Intact Cord Resuscitation in CDH
ClinicalTrials.gov ID: NCT04429750
What this study is testing
- What it's testing
- Isolated CDH is a rare disease (1/3500) and displays a wide range of severity and outcome. Despite attempts to standardize the management of this disease at birth and during the first months of life, the mortality varies from 20 to 50% according to different hospitals in France and abroad.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 36 to 37
You may be able to join if
- Antenatal diagnosis of CDH
- No severe additional malformation or chromosomal diseases
- Full term (\>36 weeks gestational age)
- No inclusion in another antenatal trial
- Written informed consents from the parents
You likely can't join if
- Preterm birth less than 37 weeks gestational age
- Other severe malformation(s) or chromosomal diseases
- Twin
- Parents who may have French language understanding difficulties may not participate to the study unless they receive appropriate assistance regarding...
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
- Lille, France
- Nantes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 36 weeks to 37 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France; Lille, France; Nantes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.